Texture analysis on diffusion tensor imaging: discriminating glioblastoma from single brain metastasis.


Journal

Acta radiologica (Stockholm, Sweden : 1987)
ISSN: 1600-0455
Titre abrégé: Acta Radiol
Pays: England
ID NLM: 8706123

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 5 6 2018
medline: 27 2 2019
entrez: 5 6 2018
Statut: ppublish

Résumé

Texture analysis has been done on several radiological modalities to stage, differentiate, and predict prognosis in many oncologic tumors. To determine the diagnostic accuracy of discriminating glioblastoma (GBM) from single brain metastasis (MET) by assessing the heterogeneity of both the solid tumor and the peritumoral edema with magnetic resonance imaging (MRI) texture analysis (MRTA). Preoperative MRI examinations done on a 3-T scanner of 43 patients were included: 22 GBM and 21 MET. MRTA was performed on diffusion tensor imaging (DTI) in a representative region of interest (ROI). The MRTA was assessed using a commercially available research software program (TexRAD) which applies a filtration histogram technique for characterizing tumor and peritumoral heterogeneity. The filtration step selectively filters and extracts texture features at different anatomical scales varying from 2 mm (fine) to 6 mm (coarse). Heterogeneity quantification was obtained by the statistical parameter entropy. A threshold value to differentiate GBM from MET with sensitivity and specificity was calculated by receiver operating characteristic (ROC) analysis. Quantifying the heterogeneity of the solid part of the tumor showed no significant difference between GBM and MET. However, the heterogeneity of the GBMs peritumoral edema was significantly higher than the edema surrounding MET, differentiating them with a sensitivity of 80% and specificity of 90%. Assessing the peritumoral heterogeneity can increase the radiological diagnostic accuracy when discriminating GBM and MET. This will facilitate the medical staging and optimize the planning for surgical resection of the tumor and postoperative management.

Sections du résumé

BACKGROUND BACKGROUND
Texture analysis has been done on several radiological modalities to stage, differentiate, and predict prognosis in many oncologic tumors.
PURPOSE OBJECTIVE
To determine the diagnostic accuracy of discriminating glioblastoma (GBM) from single brain metastasis (MET) by assessing the heterogeneity of both the solid tumor and the peritumoral edema with magnetic resonance imaging (MRI) texture analysis (MRTA).
MATERIAL AND METHODS METHODS
Preoperative MRI examinations done on a 3-T scanner of 43 patients were included: 22 GBM and 21 MET. MRTA was performed on diffusion tensor imaging (DTI) in a representative region of interest (ROI). The MRTA was assessed using a commercially available research software program (TexRAD) which applies a filtration histogram technique for characterizing tumor and peritumoral heterogeneity. The filtration step selectively filters and extracts texture features at different anatomical scales varying from 2 mm (fine) to 6 mm (coarse). Heterogeneity quantification was obtained by the statistical parameter entropy. A threshold value to differentiate GBM from MET with sensitivity and specificity was calculated by receiver operating characteristic (ROC) analysis.
RESULTS RESULTS
Quantifying the heterogeneity of the solid part of the tumor showed no significant difference between GBM and MET. However, the heterogeneity of the GBMs peritumoral edema was significantly higher than the edema surrounding MET, differentiating them with a sensitivity of 80% and specificity of 90%.
CONCLUSION CONCLUSIONS
Assessing the peritumoral heterogeneity can increase the radiological diagnostic accuracy when discriminating GBM and MET. This will facilitate the medical staging and optimize the planning for surgical resection of the tumor and postoperative management.

Identifiants

pubmed: 29860889
doi: 10.1177/0284185118780889
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-366

Auteurs

Karoline Skogen (K)

1 Department of Radiology and Nuclear Medicine, Oslo University Hospitals - Ullevål, Oslo, Norway.

Anselm Schulz (A)

1 Department of Radiology and Nuclear Medicine, Oslo University Hospitals - Ullevål, Oslo, Norway.

Eirik Helseth (E)

2 Department of Neurosurgery, Oslo University Hospitals - Ullevål, Oslo, Norway.
3 Faculty of Medicine, University of Oslo, Oslo, Norway.

Balaji Ganeshan (B)

4 Department of Nuclear Medicine, University College London, London, UK.

Johann Baptist Dormagen (JB)

1 Department of Radiology and Nuclear Medicine, Oslo University Hospitals - Ullevål, Oslo, Norway.

Andrès Server (A)

5 Department of Radiology and Nuclear Medicine, Oslo University Hospitals - Rikshospitalet, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH